A

What this means for you

Registered since 14 Oct 2014. The owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

79139640

Registration number

4619191

Mark type

Design + words

Filed

16 Oct 2013

Published for opposition

29 Jul 2014

Registered

14 Oct 2014

Attorney of record

Jeffery A. Smith

Goods and services

• Class 005 — Pharmaceuticals: [ In vitro diagnostic preparations for medical use; diagnostic test reagents for medical use; chemical reagents for medical or veterinary use; diagnostic reagents and contrast media agents for medical use; Medical diagnostic reagents; Reagents for medical use ]
• Class 009 — Scientific and electric apparatus: [ Measuring apparatus and instruments, namely, free flow electrophoresis equipment for protein separation and isolation, and flow cytometry analyzers for cellular analysis; scientific, optical, measuring, signaling and checking apparatus and instruments, namely, free flow electrophoresis equipment for protein separation and isolation, and flow cytometers for single cell and population based cellular analysis; measuring and testing machines and instruments, namely, protein separation and isolation instruments, flow cytometers, and laboratory liquid handlers and automation for testing and implementing cellular based screening methods; laboratory apparatus and instruments for use in growing, maintaining, evaluating and quality control of cell cultures, automated liquid dispensing, protein separation and isolation, single cell and population based cellular analysis, and the assessment of compound or drug effects on cellular physiology and biology, not for medical purposes; chemistry apparatus and instruments for maintaining, evaluating and quality control of cell cultures, automated liquid dispensing of compound preparations and chemical reagents, protein separation and isolation, single cell and population based cellular analysis, and the assessment of compound or drug effects on cellular physiology and biology, not for medical purpose ]
• Class 042 — Scientific and technological services: Scientific research and development; [ scientific and technological services, namely, novel multi-parametric phenotypic screening in the nature of analytical testing services and protein isolation for the characterization and simultaneous identification of multiple biological and physiological effects caused by drug candidates on live human cell models in the field of pharmaceutical research, drug discovery and characterization of compound effect, and scientific research and development relating thereto; ] Scientific and technological services for scientific analysis, testing and research in the fields of pharmaceutical research, [ drug discovery and characterization of compound effect, and protein separation, isolation and characterization; ] scientific research services; scientific testing and analysis in the fields of pharmaceutical research, [ drug discovery and characterization of compound effect, and protein separation, isolation and characterization; ] computer-assisted scientific research, testing and analysis services in the fields of pharmaceutical research, drug discovery and characterization of compound effect by using mathematical and statistical algorithms to compare and predict the effect of a target compound to that of an approved drug or known toxin, where a biological fingerprint is created and analyzed by measuring the broad physiological and biological effect of said compounds on live human cells; laboratory research and analysis services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, [ and protein separation, isolation and characterization; pharmaceutical research and development; ] Scientific research and scientific and technological services, namely, analytical testing and phenotypic screening services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, [ and protein separation, isolation and characterization; ] scientific laboratory services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds, [ and protein separation, isolation and characterization; ] scientific and technological services, namely, analytical testing and phenotypic screening services in the fields of pharmaceutical research, drug discovery [ and characterization of chemical compounds, and protein separation, isolation and characterization; provision of information about medical and scientific research in the field of pharmaceuticals; preparation of reports on scientific research ]; provision of scientific information on technological research in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds; [ provision of scientific information about industrial analysis and research services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds; provision of information and data relating to medical research and development and veterinary medical research; consultancy services in the field of pharmaceutical research; consultancy relating to research and development in the field of therapeutics; engineering and ] scientific consultancy services in the fields of pharmaceutical research, drug discovery and characterization of chemical compounds [, and protein separation, isolation and characterization; provision of technical advice in the field of scientific and industrial research; consultancy in the field of scientific and industrial research ]

Owner

• AsedaSciences AG, Schindellegi, CH
• AsedaSciences AG, CH
• AsedaSciences GmbH, CH

Prosecution history

• 09 Sept 2025 — NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
• 09 Sept 2025 — REGISTERED-SEC.71 ACCEPTED
• 13 Aug 2025 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
• 11 Aug 2025 — PETITION TO DIRECTOR DISMISSED
• 11 Aug 2025 — ASSIGNED TO PETITION STAFF
• 14 Apr 2025 — TEAS PETITION TO DIRECTOR RECEIVED
• 14 Oct 2023 — COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
• 29 Sept 2023 — INTERNATIONAL REGISTRATION RENEWED
• 07 Jun 2023 — LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
• 27 Mar 2023 — LIMITATION OF GOODS RECEIVED FROM IB
• 20 Sept 2022 — PARTIAL INVALIDATION PROCESSED BY THE IB
• 03 Aug 2022 — PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
• 03 Aug 2022 — INVALIDATION PROCESSED
• 30 Apr 2022 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
• 30 Aug 2021 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED